Whitebox Advisors’s Envoy Medical COCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-552,000
Closed -$5.53M 576
2022
Q4
$5.53M Hold
552,000
0.15% 95
2022
Q3
$5.42M Hold
552,000
0.15% 87
2022
Q2
$5.41M Hold
552,000
0.17% 84
2022
Q1
$5.39M Sell
552,000
-43,200
-7% -$420K 0.11% 83
2021
Q4
$5.8M Hold
595,200
0.12% 77
2021
Q3
$5.78M Sell
595,200
-4,800
-0.8% -$46.5K 0.12% 76
2021
Q2
$5.84M Buy
+600,000
New +$5.83M 0.12% 80

Other funds holding COCH

Whitebox Advisors's COCH Position: Q1 2023 in Review

Whitebox Advisors sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 552,000 shares — an estimated $5.53M sold.

Whitebox Advisors first reported a position in COCH in Q2 2021 and held it in 7 quarters. The position peaked at $5.84M in Q2 2021. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

  • Whitebox Advisors reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
  • Whitebox Advisors sold 552,000 Envoy Medical shares in Q1 2023, an estimated $5.53M.
  • Whitebox Advisors first reported a position in Envoy Medical in Q2 2021 and held it in 7 quarters.
  • Whitebox Advisors's Envoy Medical position peaked at $5.84M in Q2 2021.
  • 24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on Whitebox Advisors's 13F filing for Q1 2023, filed 15 May 2023.